Branched Polymer Conjugates for Active Agent Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for delivering active agents, such as polypeptides, face challenges including short half-life, immune responses, and inconvenient injection schedules due to rapid degradation and immunogenicity, particularly with long polyethylene glycol conjugates that become inactive due to blocking of active sites.

Innovation Solution

Development of polymeric reagents with a specific internal structural orientation, featuring a water-soluble polymer linked to a nitrogen atom and a reactive group, allowing for customized hydrolysis rates and improved conjugation with active agents, enhancing stability and activity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If a relatively long polyethylene glycol molecule is used to conjugate with an active agent, then water solubility is improved, but the active agent becomes substantially inactive due to blocking of active sites

Engineering Contradiction:
Improvewater solubilityVSAvoidactive agent activity
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent applies local quality by creating a branched polymer structure where different regions serve different functions: the polymer backbone provides water solubility enhancement while the branched arms are positioned to avoid blocking the active sites of the conjugated active agent. This spatial differentiation allows simultaneous achievement of solubility improvement and activity preservation.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The invention transitions from linear polyethylene glycol conjugation to a three-dimensional branched structure. This dimensional change allows the polymer to extend outward from the active agent in multiple directions, providing solubility benefits without creating the steric hindrance that blocks active sites in linear configurations.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Object-affected harmful factors

If conventional linear polyethylene glycol is used for conjugation, then immunogenicity is reduced, but the conjugate becomes inactive due to steric hindrance

Engineering Contradiction:
ImproveimmunogenicityVSAvoidconjugate activity
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The branched polymer structure creates distinct functional zones: the core region provides immunoprotection while the peripheral branches maintain accessibility of the active agent's binding sites. This local differentiation resolves the contradiction between immunogenicity reduction and activity preservation.

Inventive Principle:
Principle #3Local quality

3Duration of action of moving object

If repeated injections are administered to maintain therapeutic levels, then half-life is extended through frequent dosing, but patient convenience decreases and pain increases

Engineering Contradiction:
Improvehalf-lifeVSAvoidpatient convenience
Core Design Contradiction:
Duration of action of moving objectVSEase of operation

Solution Approach 1:

The branched polymer structure fundamentally changes the pharmacokinetic parameters of the conjugate, extending half-life through reduced renal clearance and decreased enzymatic degradation. This parameter change allows less frequent dosing intervals while maintaining therapeutic levels, improving patient convenience.

Inventive Principle:
Principle #35Parameter changes

4Quantity of substance

If marginally soluble active agents are conjugated to polyethylene glycol, then water solubility is improved, but the conjugation process becomes challenging

Engineering Contradiction:
Improvewater solubilityVSAvoidconjugation process
Core Design Contradiction:
Quantity of substanceVSEase of manufacture

Solution Approach 1:

The patent employs local quality by incorporating hydrophilic polymer segments at specific locations on the conjugate structure. These localized hydrophilic regions provide sufficient water solubility enhancement without requiring extensive modification of the entire molecule, simplifying the conjugation process.

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS7947261B2Conjugates formed from polymer derivatives having particular atom arrangements
Publication Date: 2011.05.24 NEKTAR THERAPEUTICS INC
  • US7947261B2 patent drawing
  • US7947261B2 patent drawing
  • US7947261B2 patent drawing

AI summary

Polymeric reagents are provided comprising a moiety of atoms arranged in a specific order, wherein the moiety is positioned between a water-soluble polymer and a reactive group. The polymeric reagents are useful for, among other things, forming polymer-active agent conjugates. Related methods, compositions, preparations, and so forth are also provided.